Table 2.
Pilot study in the early phase after ktx.
| Patient Characteristics | Patient 1 | Patient 2 | Patient 3 | Patient 4 |
|---|---|---|---|---|
| Recipient age (years) | 22 | 48 | 51 | 50 |
| Hemodialysis (years) | None | 6 | 12 | 12 |
| Type of ktx | living donation | postmortal, AM-Program | postmortal | postmortal |
| Plasmapheresis | no | 2× day 0 + 1 | day 15, 16, 17 | no |
| Delayed graft function | no | no | no | yes |
| Allograft biopsy (day) | n/a | n/a | 10 | 14 |
| In hospital stay (days) | 8 | 8 | 21 | 14 |
| Steroid boli for rejection treatment | n.a. | n.a. | 3× 500 mg prednisolone | 3× 500 mg prednisolone |
| Creatinine at 4 weeks after ktx (μmol/L) | 145 | 178 | 162 | 169 |